Predictive parameters for imatinib failure in patients with chronic myeloid leukemia.
Danijela LekovicMirjana GoticNatasa MilicBiljana ZivojinovicJelica JovanovicNatasa ColovicVioleta MilosevicAndrija BogdanovicPublished in: Hematology (Amsterdam, Netherlands) (2017)
The new score allows better selection of patients who are suitable for treatment with imatinib and may guideline the clinical decision for front-line treatment of CML.